GlassScriptPhysician profile
Carlotta Hillert
NPI 1225073208
$3,319.32
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,955 · 2020: $853 · 2021: $338 · 2022: $156 · 2023: $17.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,004.18 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $529.85 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $293.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $247.20 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $246.79 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $218.97 | 2019-2021 | |
| Lilly USA, LLC | $167.84 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.80 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $133.60 | 2021 | |
| Amgen INC. | $127.89 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.76 | 2019 | |
| Amarin Pharma, INC. | $50.81 | 2019-2020 | |
| Kaleo, INC. | $40.27 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.82 | 2020 | |
| Abbott Laboratories | $17.86 | 2023 | Freestyle Libre 3 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlotta Hillert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.